Your browser doesn't support javascript.
loading
Correction to: Anti-mesothelin CAR-T immunotherapy in patients with ovarian cancer.
Chen, Jiannan; Hu, Jianhua; Gu, Lili; Ji, Feng; Zhang, Fan; Zhang, Miaomiao; Li, Jun; Chen, Zhengliang; Jiang, Longwei; Zhang, Yan; Shi, Ruifang; Ma, Lihua; Jia, Shaochang; Zhang, Ying; Zhang, Qi; Liang, Junqing; Yao, Shunyu; Hu, Zhigang; Guo, Zhigang.
Afiliación
  • Chen J; Jiangsu Key Laboratory for Molecular and Medical Biotechnology, College of Life Sciences, Nanjing Normal University, Nanjing, 210023, China.
  • Hu J; Department of Biotherapy, Jinling Hospital of Nanjing University School of Medicine, Nanjing, 210002, China.
  • Gu L; Jiangsu Key Laboratory for Molecular and Medical Biotechnology, College of Life Sciences, Nanjing Normal University, Nanjing, 210023, China.
  • Ji F; Jiangsu Key Laboratory for Molecular and Medical Biotechnology, College of Life Sciences, Nanjing Normal University, Nanjing, 210023, China.
  • Zhang F; Jiangsu Key Laboratory for Molecular and Medical Biotechnology, College of Life Sciences, Nanjing Normal University, Nanjing, 210023, China.
  • Zhang M; Jiangsu Key Laboratory for Molecular and Medical Biotechnology, College of Life Sciences, Nanjing Normal University, Nanjing, 210023, China.
  • Li J; Nanjing Blue Shield Biotechnology Co., Ltd., Nanjing, 210023, China.
  • Chen Z; Nanjing Blue Shield Biotechnology Co., Ltd., Nanjing, 210023, China.
  • Jiang L; Department of Biotherapy, Jinling Hospital of Nanjing University School of Medicine, Nanjing, 210002, China.
  • Zhang Y; Department of Biotherapy, Jinling Hospital of Nanjing University School of Medicine, Nanjing, 210002, China.
  • Shi R; Department of Biotherapy, Jinling Hospital of Nanjing University School of Medicine, Nanjing, 210002, China.
  • Ma L; Department of Biotherapy, Jinling Hospital of Nanjing University School of Medicine, Nanjing, 210002, China.
  • Jia S; Department of Biotherapy, Jinling Hospital of Nanjing University School of Medicine, Nanjing, 210002, China.
  • Zhang Y; Department of Pathology, Jinling Hospital of Nanjing University School of Medicine, Nanjing, 210002, China.
  • Zhang Q; Center of Interventional Radiology and Vascular Surgery, Department of Radiology, Zhongda Hospital, Medical School, Southeast University, Nanjing, 210009, China.
  • Liang J; Inner Mongolia Autonomous Region Cancer Hospital, Hohhot, 010010, China.
  • Yao S; Baylor University, 1311 S 5Th St, Waco, USA.
  • Hu Z; Jiangsu Key Laboratory for Molecular and Medical Biotechnology, College of Life Sciences, Nanjing Normal University, Nanjing, 210023, China. huzg_2000@126.com.
  • Guo Z; Jiangsu Key Laboratory for Molecular and Medical Biotechnology, College of Life Sciences, Nanjing Normal University, Nanjing, 210023, China. guo@njnu.edu.cn.
Cancer Immunol Immunother ; 72(10): 3401-3403, 2023 Oct.
Article en En | MEDLINE | ID: mdl-37578659
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Cancer Immunol Immunother Asunto de la revista: ALERGIA E IMUNOLOGIA / NEOPLASIAS / TERAPEUTICA Año: 2023 Tipo del documento: Article País de afiliación: China
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Cancer Immunol Immunother Asunto de la revista: ALERGIA E IMUNOLOGIA / NEOPLASIAS / TERAPEUTICA Año: 2023 Tipo del documento: Article País de afiliación: China